Germany provides a broad spectrum of biotech locations across the country. We present short profiles of the major regions with its core competences, main stakeholders and networks.
Mainz has become an important address for biotechnology, especially in recent years. With the breakthrough of BioNTech, not only the industry but also the location Mainz has experienced a major upswing.
Both large, traditional companies and innovative biotech SMEs find an optimal environment for the development of new technologies and products in Hessen, surrounded by numerous research institutes and first-class universities.
Various universities, research institutions and companies form a successful life sciences network in Mecklenburg-Vorpommern. This network is becoming increasingly important as a driver of innovation.
In the Berlin-Brandenburg capital region, companies, start-ups, researchers and clinics work together on top performance for the regional and global healthcare market.
Northern Germany, with its expertise in pharmaceuticals, biotech and medical technology, is a well-established location for the life science industry. The focus is on precision medicine, diagnostics and laboratory supplies.
Munich and the surrounding area are considered a strongly networked biotech region and are home to numerous players - from pharmaceutical or chemical companies and medium-sized enterprises to research centers, clinics and start-ups.
Lower Saxony is a growing life science location where various disciplines interact, create synergies in joint networks and develop a high level of innovative strength.
The metropolitan area of North Rhine-Westphalia has a high density of biotech companies that are active both in healthcare and in sustainable bioeconomy.
The Rhine-Neckar metropolitan region has a dense network of stakeholders in science and business who are committed to developing innovative solutions in medicine.
A lot of money has been invested in Saxony to develop the region into a dynamic life science location. Vital clusters are particularly active around the two major biotechnology centers in Dresden and Leipzig.
The Stuttgart and Neckaralb regions are characterized by a unique mix of biotechnology and medical technology companies as well as the regional clusters of automation technology and mechanical and plant engineering.
Stay informed!
We send the BIOTECH Insight Newsletter four times a year. Register now and receive sector-relevant updates regularly by e-mail.
